Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2

Published:2021-09 Issue: Volume:141 Page:111902
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Morsy Mohamed A.,Khalaf Hanaa M.,Rifaai Rehab A.,Bayoumi Asmaa M.A.,Khalifa Esraa M.M.A.,Ibrahim Yasmine F.

Funder

Deanship of Scientific Research, King Faisal University

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference111 articles.

1. Immunopathogenesis of IBD: current state of the art;de Souza;Nat. Rev. Gastroenterol. Hepatol.,2016

2. Preventive health measures in inflammatory bowel disease;Abegunde;World J. Gastroenterol.,2016

3. Comorbidity in inflammatory bowel disease;Román;World J. Gastroenterol.,2011

4. Cytokines in inflammatory bowel disease;Neurath;Nat. Rev. Immunol.,2014

5. Understanding inflammatory bowel disease via immunogenetics;de Lange;J. Autoimmun.,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-10

2. Rutin mitigates acetic acid-induced ulcerative colitis: novel coloprotective mechanism;Toxicology Research;2024-07-01

3. SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits;Cardiovascular Research;2024-03-08

4. Drug Safety Evaluation of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Comorbid Patients by Review of Systemic Extraglycemic Effects;Diabetes, Metabolic Syndrome and Obesity;2024-03

5. Canagliflozin alleviates experimentally induced benign prostate hyperplasia in a rat model: exploring potential mechanisms involving mir-128b/EGFR/EGF and JAK2/STAT3 signaling pathways through in silico and in vivo investigations;European Journal of Pharmacology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3